A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
PHASE1CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
September 30, 1991
Study Completion Date
May 31, 2000
Conditions
Ovarian Neoplasms
Interventions
DRUG
taxol
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001272 - A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients | Biotech Hunter | Biotech Hunter